Part of European Union (Withdrawal) Bill – in the House of Commons at 3:45 pm on 13 December 2017.
The hon. Lady is making an important point. Is she also mindful of the fact that, at a critical time for the future of the pharmaceuticals industry, there is currently no certainty even on cross-border production, which many of our companies are involved in, including GlaxoSmithKline in my constituency?